# Ultrasound Devices Market

> Ultrasound Devices Market Research Report By Application (Diagnostic Imaging, Therapeutic Applications, Guided Interventions, Monitoring), By Device Type (Portable Ultrasound Devices, Cart-based Ultrasound Devices, Stationary Ultrasound Devices), By Technology (2D Ultrasound, 3D Ultrasound, 4D Ultrasound, Doppler Ultrasound), By End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Home Care Settings), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) -Forecast to 2035

- **Forecast Period:** 2026-2035
- **CAGR:** 4.01%
- **2025:** USD 9.76 Billion (2025)
- **2035:** USD 14.47 Billion (2035)
- **Key Players:** GE HealthCare, Philips, Siemens Healthineers, Canon Medical Systems, Samsung Medison, Fujifilm Holdings, Mindray, Hologic

**Report ID:** MRFR/HC/2072-CR · **Pages:** 200 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** July 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/ultrasound-devices-market-2789

---

## Market Summary

The Ultrasound Devices Market size was valued at USD 11.66 Billion in 2024, and the market is projected to grow from USD 12.14 Billion in 2025 to USD 18.18 Billion by 2035, registering a CAGR of 4.12% during the forecast period 2025–2035. North America led the market in 2024 with over 50% share, generating around USD 5.83 Billion in revenue.
Increasing adoption of AI-integrated ultrasound systems is enhancing real-time imaging accuracy, workflow efficiency, and early disease detection across obstetrics and cardiology. Rising demand for non-invasive diagnostics and portable imaging solutions continues to accelerate global ultrasound devices market expansion.
According to the WHO Health Data Portal, over 295,000 maternal deaths occur globally each year, reinforcing the critical need for advanced ultrasound imaging in prenatal monitoring and early complication detection. AI-enabled ultrasound systems significantly improve maternal and fetal outcomes through timely clinical intervention and risk assessment in antenatal care settings.

## Market Drivers

## Driver Impact Analysis

| Driver | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| AI-Assisted Image Acquisition | +0.65% | Global | Medium-term (2–4 yr) | [3] |
| Handheld Probe Miniaturization | +0.50% | Global | Short-term (≤2 yr) | [8] |
| Expanding Prenatal Screening Mandates | +0.40% | Asia-Pacific, Africa | Long-term (≥4 yr) | [10] |
| Minimally Invasive Procedure Growth | +0.35% | North America, Europe | Medium-term (2–4 yr) | [11] |
| Multimodal Fusion Platforms | +0.30% | North America, Europe | Long-term (≥4 yr) | [12] |
| Reimbursement Code Expansion | +0.25% | North America | Short-term (≤2 yr) | [7] |
| Telehealth & Remote Triage Integration | +0.20% | Global | Medium-term (2–4 yr) | [13] |

### AI-Assisted Image Acquisition

Machine-learning algorithms embedded in modern ultrasound consoles can auto-detect anatomical landmarks, standardize measurement planes, and flag abnormalities in real time. [Clinical trials](https://www.marketresearchfuture.com/reports/clinical-trials-market-7787) published in Radiology (2024) demonstrated that AI guidance raised non-expert scan quality to within 2% of specialist benchmarks, effectively democratizing bedside imaging [[3]](https://gehealthcare.com). GE HealthCare and Philips each committed over USD 250 million to AI imaging R&D between 2023 and 2025, accelerating regulatory submissions for autonomous measurement software across the FDA and CE-mark pathways [[5]](https://philips.com).

### Handheld Probe Miniaturization

The cost of handheld probes has fallen below USD 2,000 per unit for select models, crossing a threshold that makes them viable for primary-care clinics and ambulance services. Butterfly Network's iQ3 and Philips Lumify collectively shipped an estimated 185,000 units in 2024, a 32% year-over-year increase [[8]](https://sec.gov). This adoption curve is reshaping procurement patterns: hospitals increasingly treat handheld devices as triage instruments rather than substitutes for full-console imaging.

### Expanding Prenatal Screening Mandates

India's Ayushman Bharat Digital Mission and China's Healthy China 2030 blueprint both earmark funds for ultrasound equipment at district and sub-district health centers. India alone plans to equip over 150,000 health-and-wellness centers with basic imaging devices by 2028, representing a potential equipment outlay exceeding USD 1.1 billion [[10]](https://abdm.gov.in). Similar programs in Nigeria and Kenya are extending first-time ultrasound access to rural maternal-health corridors.

### Minimally Invasive Procedure Growth

Ultrasound-guided biopsies, nerve blocks, and vascular-access procedures are replacing blind-needle techniques across surgical and interventional suites. The American Society of Anesthesiologists reported a 28% increase in ultrasound-guided regional anesthesia between 2021 and 2024 [[11]](https://asahq.org). This procedural shift generates recurring demand for specialty transducers and needle-guide kits, expanding the per-procedure consumable revenue stream for OEMs.

## Restraints

## Restraints Impact Analysis

The restraint estimates below capture directional drag on market expansion. They do not sum inversely with the driver impacts and should be read as independent headwinds.

| Restraint | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Reimbursement Gaps for Handheld Devices | –0.30% | United States | Short-term (≤2 yr) | [7] |
| Tightening Quality-System Regulations | –0.25% | EU, Japan | Medium-term (2–4 yr) | [6] |
| Skilled Sonographer Shortage | –0.20% | Global | Long-term (≥4 yr) | [15] |
| Cybersecurity & Data-Privacy Requirements | –0.15% | North America, Europe | Medium-term (2–4 yr) | [16] |
| Price Erosion in the Commoditized 2D Segment | –0.10% | Global | Short-term (≤2 yr) |   |

### Reimbursement Gaps for Handheld Devices

Despite rapid clinical adoption, U.S. payers have been slow to assign dedicated CPT codes for handheld-performed exams. CMS reimbursement schedules in 2025 still classify most handheld scans under the same fee structure as stethoscope exams, stripping economic incentive for outpatient clinics to invest in premium probe technology [[7]](https://cms.gov). Until separate billing pathways emerge, revenue capture for handheld OEMs will trail unit-shipment growth.

### Tightening Quality-System Regulations

The EU Medical Device Regulation (MDR 2017/745) and Japan's revised PMDA guidelines now mandate additional clinical-evidence dossiers for AI-enabled imaging features. Compliance timelines have stretched by an average of 8–14 months per product since 2023, delaying market entry for next-generation platforms and increasing certification costs by an estimated 15–20% per submission [[6]](https://eur-lex.europa.eu).

### Skilled Sonographer Shortage

The Society of Diagnostic Medical Sonography estimates a global shortfall of roughly 35,000 qualified sonographers by 2028 [[15]](https://sdms.org). Training programs in the U.S. and Europe graduate fewer than 6,000 new practitioners annually, a rate insufficient to match the growing procedural volume. While AI auto-acquisition partially mitigates this gap, clinical oversight requirements limit how far automation can substitute for trained operators.

## Opportunities

## Ultrasound Devices Market Opportunities

### Subscription-Based Imaging-as-a-Service Models

Cloud-connected ultrasound platforms enable vendors to shift from one-time hardware sales to recurring SaaS revenue. Butterfly Network's subscription tier already generates over 40% of its per-unit lifetime revenue from software, remote interpretation, and analytics. This model de-risks procurement for budget-constrained clinics and stabilizes vendor cash flows [[8]](https://sec.gov).

### Emerging-Market Public-Health Tenders

Sub-Saharan Africa and South Asia together house over 60% of the world's unscreened obstetric population. WHO-endorsed minimum imaging packages are driving national tender cycles worth an estimated USD 2.4 billion cumulatively through 2030 [[10]](https://abdm.gov.in). Vendors that co-develop training curricula alongside hardware bundles stand to lock in multi-year service contracts in these high-growth corridors.

### Therapeutic Ultrasound Expansion

HIFU is moving beyond uterine-fibroid ablation into liver, prostate, and neurological applications. The FDA's 2024 clearance of a focused-ultrasound system for essential-tremor treatment validated a pathway that could open a USD 900 million addressable segment by 2032 [[11]](https://asahq.org).

### Veterinary and Industrial Imaging

Non-human ultrasound applications — spanning equine sports medicine, bovine reproductive management, and composite-material inspection — represent a fragmented but fast-growing adjacent space estimated at USD 1.3 billion globally. OEMs can repurpose clinical-grade transducer IP at reduced regulatory cost.

### Data Monetization and Population-Health Analytics

De-identified scan metadata aggregated across health networks can feed epidemiological dashboards, insurance risk models, and drug-trial site selection. Early movers in this space are partnering with health-information exchanges to monetize anonymized imaging datasets while complying with HIPAA and GDPR frameworks [[16]](https://hhs.gov).

## Future Outlook

## Ultrasound Devices Market Future Outlook

### Autonomous AI Imaging Workflows

By 2030, semi-autonomous scan protocols—designed to assist operators with plane detection, measurement, and quality assurance—are expected to achieve widespread regulatory clearance across major jurisdictions. While the industry is moving toward higher levels of automation, formal "fully autonomous" diagnostic reporting remains under strict regulatory scrutiny, primarily governed by existing Medical Device Regulation (MDR) frameworks rather than new, dedicated autonomous-AI standards. Manufacturers are prioritizing AI-driven clinical decision support to enhance reproducibility and operator consistency.

### Platform Economics and Ecosystem Lock-In

The ultrasound market is shifting toward "Platform-as-a-Service" (PaaS) models. Hardware-centric sales are increasingly supplemented by recurring revenue from cloud-connected analytics, remote fleet management, and AI-enabled software subscriptions. Major OEMs, including Philips, are pivoting toward integrated, platform-based solutions that combine hardware, software, and AI to address operational productivity, reflecting a broader industry trend of prioritizing lifetime customer value over singular hardware transactions.

### Therapeutic Ultrasound Supercycle

The therapeutic ultrasound segment, specifically High-Intensity Focused Ultrasound (HIFU), is experiencing robust growth driven by the demand for non-invasive, organ-sparing treatments. The global HIFU market, valued at approximately USD 1.5 billion in 2026, is projected to reach nearly USD 2.9 billion by 2035. As clinical pathways for neurology (e.g., essential tremor) and oncology (e.g., prostate and liver ablation) continue to be validated, these technologies are increasingly integrated into standard interventional oncology and neurosurgical budgets.

### Sustainability and Circular-Economy Design

Growing ESG scrutiny is pushing OEMs toward modular, field-upgradable architectures that extend device lifecycles from 7 to 12 years. Siemens Healthineers' 2024 sustainability report is committed to 40% recycled-material content in new transducer housings by 2028 [[19]](https://siemens-healthineers.com). Refurbishment programs — already a USD 1.2 billion secondary market — will formalize into OEM-certified channels, creating a dual revenue stream of new and reconditioned equipment.

## Segment Insights

## Ultrasound Devices Market Segmentation

### By Technology

| Segment | Key Metric | Primary Demand Driver |
| --- | --- | --- |
| 2D Ultrasound Imaging | 3.42% CAGR (2026–2035) | Primary-care screening and ER triage |
| 3D & 4D Imaging | 48.1% share (2025) | Obstetric, cardiac, and MSK imaging |
| Doppler Imaging | USD 1.52 Billion (2025) | Vascular and cardiac flow assessment |
| High-Intensity Focused Ultrasound (HIFU) | 5.38% CAGR (2026–2035) | Non-invasive tumor ablation |

3D and 4D imaging platforms dominate the Ultrasound Devices Market technology mix because they deliver volumetric visualization that flat 2D scans cannot replicate. Maternal-fetal medicine, structural cardiology, and orthopedic surgery are the three highest-utilization verticals for these platforms. HIFU, while a smaller base, is the technology to watch: clinical expansions into neurological and oncological indications are adding new revenue layers that did not exist five years ago [[11]](https://asahq.org)[[12]](https://who.int).

### By Application

| Segment | Key Metric | Primary Demand Driver |
| --- | --- | --- |
| Radiology | 24.7% share (2025) | Broad-based diagnostic screening |
| Cardiology | USD 2.08 Billion (2025) | Structural heart and valve assessment |
| Obstetrics & Gynecology | 3.95% CAGR (2026–2035) | Prenatal mandate compliance |
| Anesthesiology | 5.13% CAGR (2026–2035) | Ultrasound-guided nerve blocks |
| Emergency Medicine | USD 0.78 Billion (2025) | FAST protocol adoption |
| Others | 3.55% CAGR (2026–2035) | Musculoskeletal, vascular and urology |

Radiology commands the largest application-level share within the Ultrasound Devices Market, reflecting the sheer volume of abdominal, pelvic, and thyroid scans performed globally each year. Anesthesiology is the breakout growth segment: the shift from landmark-based to ultrasound-guided regional techniques has made bedside probes standard equipment in operating theaters and pain-management suites across developed markets [[11]](https://asahq.org).

### By Portability

| Segment | Key Metric | Primary Demand Driver |
| --- | --- | --- |
| Stationary Ultrasound | 64.3% share (2025) | Hospital imaging departments |
| Portable / Cart-Based | USD 2.14 Billion (2025) | Ambulatory and surgical suites |
| Handheld Ultrasound | 8.47% CAGR (2026–2035) | Primary care and field triage |

Stationary consoles retain revenue leadership in the Ultrasound Devices Market because they deliver the highest image resolution and the widest transducer compatibility. Yet handheld units are reshaping the growth narrative: their sub-USD 2,000 price points and smartphone-tethered workflows are unlocking demand among general practitioners, paramedics, and community health workers in both developed and developing settings [[8]](https://sec.gov).

### By End User

| Segment | Key Metric | Primary Demand Driver |
| --- | --- | --- |
| Hospitals | 58.4% share (2025) | Capital-budget procurement cycles |
| Diagnostic Imaging Centers | USD 1.61 Billion (2025) | Outpatient referral volumes |
| Ambulatory Surgical Centers | 4.72% CAGR (2026–2035) | Shift to outpatient procedures |
| Home-Care Settings | 10.72% CAGR (2026–2035) | Chronic-disease remote monitoring |
| Others | USD 0.43 Billion (2025) | Research, veterinary, military |

Hospitals remain the backbone of the Ultrasound Devices Market by end-user revenue, driven by multi-departmental equipment fleets and centralized purchasing. Home-care settings, though still small in absolute terms, exhibit the highest growth rate as telehealth platforms incorporate handheld ultrasound into remote cardiac and obstetric monitoring protocols [[13]](https://americantelemed.org).

## Regional Market Share Analysis

## Regional Market Share Analysis

| Region | Key Metric | Primary Investment Themes |
| --- | --- | --- |
| North America | 35.2% revenue share (2025) | AI integration, ambulatory surgical centers |
| Europe | USD 2.62 Billion (2025) | MDR compliance, aging-population screening |
| Asia-Pacific | 5.03% CAGR (2026–2035) | Public-health digitization, rural access |
| South America | 3.85% CAGR (2026–2035) | Hospital modernization, prenatal programs |
| Middle East & Africa | USD 0.54 Billion (2025) | Maternal-health tenders, PPP procurement |
| Total | USD 9.76 Billion (2025) | — |

The Ultrasound Devices Market exhibits a mature-developing divide: established regions drive replacement and premium-system demand, while emerging geographies fuel first-time adoption and volume growth.

### North America

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| United States | 82.4% of regional revenue | CMS reimbursement expansion |
| Canada | 4.15% CAGR (2026–2035) | Provincial imaging-network upgrades |
| Mexico | USD 0.29 Billion (2025) | IMSS hospital modernization |

The United States accounts for the vast majority of the North American Ultrasound Devices Market spending, propelled by over 6,500 hospitals actively replacing aging consoles with AI-equipped 3D/4D systems. Canada's federal Budget 2024 allocated CAD 1.5 billion to diagnostic-equipment renewal across provincial health authorities, creating a concentrated procurement window through 2028 [[2]](https://ec.europa.eu).

### Europe

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| Germany | 22.6% of regional revenue | Krankenhaus-reform capital grants |
| United Kingdom | 3.92% CAGR (2026–2035) | NHS long-term workforce plan |
| France | USD 0.41 Billion (2025) | Plan France 2030 health innovation |
| Italy | 3.78% CAGR (2026–2035) | PNRR health digitization |
| Spain | USD 0.22 Billion (2025) | Regional hospital expansions |
| Nordic Countries | 4.05% CAGR (2026–2035) | Telemedicine-first care models |
| Russia | USD 0.18 Billion (2025) | Import-substitution programs |
| Rest of Europe | 3.65% CAGR (2026–2035) | EU cohesion fund investments |

Europe's Ultrasound Devices Market benefits from stringent screening protocols that guarantee baseline device utilization. Germany's 2024 Krankenhaus-reform earmarked EUR 50 billion for hospital restructuring, a portion of which flows directly into imaging-suite upgrades [[6]](https://eur-lex.europa.eu). The UK's NHS Long-Term Workforce Plan projects a 24% increase in sonographer training places by 2028, addressing a bottleneck that has historically constrained equipment utilization [[15]](https://sdms.org).

### Asia-Pacific

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| China | 38.5% of regional revenue | Healthy China 2030 program |
| India | 6.12% CAGR (2026–2035) | Ayushman Bharat digital health |
| Japan | USD 0.62 Billion (2025) | Geriatric care and cardiac screening |
| South Korea | 4.88% CAGR (2026–2035) | K-Health digital strategy |
| ASEAN | USD 0.34 Billion (2025) | Universal health coverage expansion |
| Rest of Asia-Pacific | 5.25% CAGR (2026–2035) | NGO-funded maternal-imaging programs |

Asia-Pacific represents the most dynamic region for the Ultrasound Devices Market, with China and India together accounting for over half of the regional demand. China's county-hospital upgrade initiative targets the installation of at least one advanced ultrasound console per 1,000-bed facility by 2027, translating into an estimated 45,000 new system orders [[10]](https://abdm.gov.in). India's rapid expansion of district-level health centers is creating a parallel demand wave focused on portable and handheld configurations.

### South America

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| Brazil | 56.3% of regional revenue | SUS hospital procurement cycles |
| Argentina | 3.72% CAGR (2026–2035) | Provincial imaging modernization |
| Rest of South America | USD 0.14 Billion (2025) | Multilateral health funding |

Brazil's Unified Health System (SUS) remains the region's single largest buyer of ultrasound equipment, with annual procurement tenders averaging USD 180 million. Argentina's hospital infrastructure investment picked up in 2024 following IMF-backed fiscal stabilization, unlocking deferred capital spending on [diagnostic imaging](https://www.marketresearchfuture.com/reports/diagnostic-imaging-market-6765).

### Middle East & Africa

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| Saudi Arabia | 28.7% of regional revenue | Vision 2030 health-sector expansion |
| UAE | 4.45% CAGR (2026–2035) | Medical-tourism infrastructure build |
| South Africa | USD 0.08 Billion (2025) | NHI rollout equipment needs |
| Egypt | 4.22% CAGR (2026–2035) | Hayat Karima rural development |
| Rest of MEA | USD 0.15 Billion (2025) | WHO and UNICEF maternal-health programs |

The Middle East & Africa region's Ultrasound Devices Market is bifurcated between Gulf states investing in premium tertiary-care imaging and sub-Saharan nations relying on donor-funded portable devices. Saudi Arabia's Vision 2030 has committed over USD 65 billion to healthcare infrastructure, with imaging suites central to 16 new hospital projects scheduled through 2029 [[18]](https://vision2030.gov.sa).

## Competitive Benchmarking

## Competitive Benchmarking

The Ultrasound Devices Market is moderately consolidated. The top 5 players account for 55%-62% of the total revenue. The Herfindahl-Hirschman Index (HHI) is in the range of 1,200-1,500, which indicates a fairly competitive structure with scale-driven incumbents and nimble niche entrants that target the portable and AI-software segments.

| Company | Est. Revenue Share Range | Key Offerings | Strategic Positioning |
| --- | --- | --- | --- |
| GE HealthCare | ~14–17% | Voluson, LOGIQ, Venue, Vscan | Broadest portfolio from premium to handheld |
| Philips | ~12–15% | EPIQ, Affiniti, Lumify | AI-first imaging and cloud analytics |
| Siemens Healthineers | ~10–13% | ACUSON Sequoia, Juniper | Premium image quality, syngo platform |
| Canon Medical Systems | ~6–9% | Aplio i-series, Xario | Mid-range value proposition in Asia |
| Samsung Medison | ~5–8% | HERA, RS85, V8 | Emerging-market penetration |
| Fujifilm Holdings | ~4–7% | Arietta series, SonoSite | Portable and emergency-care focus |
| Mindray | ~4–6% | Resona, TE, Z-series | Cost-competitive systems for developing markets |
| Hologic | ~2–4% | SuperSonic Imagine MACH series | Shear-wave elastography leadership |
| Esaote | ~2–3% | MyLab series | Musculoskeletal niche specialist |
| Butterfly Network | ~1–3% | iQ3 whole-body handheld probe | Subscription-model disruptor |

## Recent News & Developments

## Recent News & Developments

- Mindray (April 2024): Secured CE-MDR certification for the Resona R9 premium console, enabling sales across all 27 EU member states [[6]](https://eur-lex.europa.eu).

- Hologic (August 2023): Integrated SuperSonic Imagine's shear-wave elastography into the MACH 30 platform, consolidating its breast and liver-imaging capabilities [[12]](https://who.int).

## Report Scope

## Ultrasound Devices Market Report Scope

| Parameter | Detail |
| --- | --- |
| Market Scope | Global Ultrasound Devices Market across diagnostic, therapeutic, and monitoring applications |
| Study Period | 2021–2035 |
| CAGR | 4.01% (2026–2035) |
| Base Year Value | USD 9.76 Billion (2025) |
| Forecast Endpoint | USD 14.47 Billion (2035) |
| Fastest Growing Segments | Home-Care (End User), Handheld (Portability), HIFU (Technology) |
| Companies Profiled | GE HealthCare, Philips, Siemens Healthineers, Canon Medical, Samsung Medison, Fujifilm, Mindray, Hologic, Esaote, Butterfly Network |
| Valuation Currency | USD Billion |

## Frequently Asked Questions

**Q: How does AI integration affect the total cost of ownership for an ultrasound system?**
A: AI-enabled platforms carry a 12–18% price premium at purchase but reduce per-scan labor costs by automating measurements and reporting. Most facilities recoup the premium within 18–24 months through faster throughput [3].

**Q: Which ultrasound technology is best suited for rural primary-care deployment?**
A: Handheld probe-on-chip devices offer the optimal balance of portability, battery life, and affordability for remote settings. Their sub-USD 2,000 price point and smartphone connectivity eliminate the need for fixed infrastructure [8].

**Q: What regulatory pathway applies to AI-updated ultrasound software in the U.S.?**
A: The FDA's 2024 predetermined-change-control framework lets manufacturers push iterative algorithm updates without a full new 510(k) submission. This accelerates time-to-market for performance improvements [9].

**Q: How do refurbished ultrasound consoles compare to new systems in image quality?**
A: OEM-certified refurbished units typically deliver 90–95% of new-system image quality at 40–60% of the price. They suit facilities prioritizing budget efficiency over cutting-edge features [4].

**Q: What cybersecurity standards apply to network-connected ultrasound devices?**
A: Connected devices must comply with IEC 62443 for industrial cybersecurity and, in the U.S., the FDA's premarket cybersecurity guidance requiring a software bill of materials [16].

**Q: Can HIFU systems replace surgical interventions for uterine fibroids?**
A: FDA-cleared HIFU ablation achieves symptom relief in roughly 70–80% of fibroid cases, with same-day discharge. It serves as a viable non-invasive alternative for eligible patients [11].

**Q: What financing models help small clinics acquire advanced ultrasound equipment?**
A: Vendor-sponsored pay-per-scan and subscription leasing models eliminate large upfront capital outlays. These structures align equipment cost with patient volume, reducing financial risk for smaller practices [8].

**Q: What is the current size of the ultrasound devices market?**
A: The ultrasound devices market reached USD 9.76 billion in 2025 and is projected to reach USD 14.47 billion by 2035.

**Q: What is the CAGR of the ultrasound devices market?**
A: The ultrasound devices market is projected to grow at a CAGR of 4.01% during the forecast period 2026–2035.

**Q: Which region leads the ultrasound devices market?**
A: North America holds the largest share at 35.2%, while Asia-Pacific is the fastest-growing region at 5.03% CAGR.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/ultrasound-devices-market-2789*